| Literature DB >> 34307628 |
Na Chen1, Da-Shun Zeng2, Yu-Tong Su3.
Abstract
BACKGROUND: Although the presentations of Sjögren's syndrome (SS) are variable, ranging from mild dryness to wider systemic involvement, ranulas as early clinical signs were scarcely reported. Here, we present an adult patient with SS, who developed a unilateral simple ranula and was diagnosed primary SS 3 years later. We also provide a review of cases of SS and ranulas from 1980 to 2020. CASEEntities:
Keywords: Case report; Early diagnosis; Parotitis; Ranulas; Sjögren’s syndrome
Year: 2021 PMID: 34307628 PMCID: PMC8281396 DOI: 10.12998/wjcc.v9.i20.5701
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.337
Figure 1Clinical picture of the unilateral (left) simple ranula.
Figure 2Histopathological findings of the sublingual gland. Chronic multifocal lymphocytic infiltration and ductal epithelial destruction are visible in the sublingual gland. Hematoxylin and eosin staining; magnification: × 40 (A) and × 100 (B).
Laboratory parameters of the patient with primary Sjögren’s syndrome who had a ranula before
|
|
|
|
|
|
|
| WBC (× 109/L) | 3.42↓ | 3.97 | 4.25 | 4.79 | 4.25 |
| Neutrophils, % | 49.1↓ | 55.8 | 55.6 | 60.2 | 55.6 |
| Lymphocytes, % | 43.3↑ | 35.7 | 36.6 | 31.9 | 36.6 |
| ESR (mm/h) | 33↑ | 17 | 10 | 17 | 7 |
| ALT (U/L) | 23 | 18 | 17 | 13 | 24 |
| AST (U/L) | 31 | 23 | 27 | 24 | 29 |
| Creatinine (μmol/L) | 67 | 66 | 86 | 76 | 68 |
| EGFR (mL/min) | 110.5 | 112.5 | 81.7 | 94.2 | 107.8 |
| ANA | 1:320 | - | - | 1:320 | 1:320 |
| Anti-dsDNA antibody | Negative | - | - | Negative | Negative |
| Anti-RNP/Sm antibody | Negative | - | - | Negative | Negative |
| Anti-Sm antibody | Negative | - | - | Negative | Negative |
| Anti-SSA antibody | Positive | - | - | Positive | Positive |
| Anti-SSB antibody | Positive | - | - | Positive | Positive |
| IgA (g/L) | 1.60 | - | - | 1.66 | 1.57 |
| IgG (g/L) | 20.10↑ | - | - | 15.9↑ | 14.47 |
| IgM (g/L) | 1.15 | - | - | 1.00 | 1.08 |
| C3 (g/L) | 0.69↓ | - | - | 0.75↓ | 1.05 |
| C4 (g/L) | 0.18 | - | - | 0.19 | 0.26 |
| RF (IU/mL) | 441↑ | - | - | 165↑ | 46.86↑ |
WBC: White blood cells; ESR: Erythrocyte sedimentation rate; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; EGFR: Estimate glomerular filtration rate; ANA: Anti-nuclear antibody; dsDNA: Double-stranded DNA; RNP: Ribonucleoprotein; SSA: Sjögren’s syndrome–related antigen A; SSB: Sjögren’s syndrome–related antigen B; Ig: Immunoglobulin; C3: Complement component 3; C4: Complement component 4; RF: Rheumatoid factor.
Review of primary Sjögren’s syndrome patients associated with ranulas
| Ref. | Country | No. of cases | Age/gender | First visit department | Type of ranula | Sicca symptoms | Extra-landular symp-toms | Time interval between pSS diagnosis and detection of ranula | Antibody positivity | Treatment of ranula | Treatment of pSS | Outcome | |
| Katayama | Japan | 2 | 33, F; 34, F | Patient 1: dermatology department Patient 2: NA | Unilateral | Patient 1: oral dryness, caries, alopecia, and pruritic skin rash Patient 2: oral dryness | NA | Patient 1: after SSPatient 2: 7 yr after SS | ANA, SSA | Surgically treated | NA | NA | |
| Pinheiro | Brazil | 1 | 37, F | Clinic of the Dental School | Unilateral | Irritation of the eyes, enlargement of the parotid glands, and dry mouth | NA | 1 yr after SS | ANA, SSA and SSB | Surgically treated | Prednisone, methotrexate, chloroquine diphosphate, and artificial tears and saliva | Improving all signs and symptoms | |
| Means | United States | 1 | 10, M | Pediatric Otolaryngology clinic | Bilateral | Bilateral recurrent parotitis, dry eyes, dental caries | NA | 4 yr before SS | ANA, SSA and SSB | Transoral excision and marsupial-zation | Routine follow-up | NA | |
| Lieberman | United States | 2 | 12, F; 8, F | Patient 1: Dental Department; Patient 2: Otolaryngology | Patient 1: Bilateral; Patient 2: Unilateral | Patient 1: Recurrent parotid gland discomfort; Patient 2: No | Patient 1: Severe joint pain; Patient 2: no | Patient 1: 7 yr before SS; Patient 2: Simultaneous | Patient 1: SS-APatient 2: ANA, SSA, SSB and RF | Patient 1: surgically treated; Patient 2: Surgically treated | NA | Patient 1: NAPatient 2: Developed significant dry eyes | |
| Sato | Japan | 3 | 66, F; 30, F; 26, F | Department of Oral Medicine | NA | NA | NA | Simultaneous | SSA, SSB | Patients 1 and 2: Surgically treated; Patient 3: Naturally resolved | NA | NA | |
| Takagi | Japan | 7 | 12, M33, F41, F43, F46, F48, F51, F | NA | Patient 1: Bilateral, plunging; Patients 2-7: NA, simple | NA | NA | Patient 1: Simultaneous; Patients 2-7: NA, but before SS | Patient 1: ANA, SSA, SSB and RF; Patients 2-7: NA | Patient 1: Open fenestration; Patients 2-7: NA | Patient 1: Mizoribine and cortices-teroid medication; Patients 2-7: NA | Patient 1: Developed parotitis after 9 mo; Patients 2-7: NA | |
| Present case | China | 1 | 25, F | Oral surgery | Unilateral, simple | Ranula and recurrent parotitis | No | 3 yr before SS | ANA, SSA and RF | Surgically treated | Hydroxychloroquine sulfate and total glycosides of paeony root capsule | No symptoms | |
M: Male; F: Female; pSS: Primary Sjögren’s syndrome; ANA: Antinuclear antibodies; SSA: Sjögren’s syndrome–related antigen A; SSB: Sjögren’s syndrome–related antigen B; RF: Rheumatoid factor; NA: Not available.